The latest closing stock price for SpringWorks Therapeutics as of February 21, 2025 is 58.25.
An investor who bought $1,000 worth of SpringWorks Therapeutics stock at the IPO in 2019 would have $1,574 today, roughly 2 times their original investment - a 20.82% compound annual growth rate over 5 years.
The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
The SpringWorks Therapeutics 52-week high stock price is 62.00, which is 6.4% above the current share price.
The SpringWorks Therapeutics 52-week low stock price is 28.21, which is 51.6% below the current share price.
The average SpringWorks Therapeutics stock price for the last 52 weeks is 39.87.
An investor who bought $1,000 worth of SpringWorks Therapeutics stock at the IPO in 2019 would have $1,574 today, roughly 2 times their original investment - a 20.82% compound annual growth rate over 5 years.
The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
The SpringWorks Therapeutics 52-week high stock price is 62.00, which is 6.4% above the current share price.
The SpringWorks Therapeutics 52-week low stock price is 28.21, which is 51.6% below the current share price.
The average SpringWorks Therapeutics stock price for the last 52 weeks is 39.87.